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(PRO). There is no standardised way how to best integrate PRO
measures into routine clinical practice. The aim of this study
was to test an electronic approach utilizing touch-screens to
implement PRO assessments into routine clinical practice.
METHODS: Cardiac patients attending an inpatient (study 1) or
outpatient (study 2) ExCR programme completed a PRO assess-
ment at the beginning and end of the ExCR programme. The
assessment was performed with a touch-screen computer includ-
ing the EQ-5D, Short-form 36 and the MacNew Heart Disease
QoL Questionnaire (MacNew). Outcome criteria were the feasi-
bility of the system, user satisfaction and the psychometric prop-
erties of the newly presented format. RESULTS: In total 296
patients with coronary artery disease (study 1: 165 patients, 67%
male, age: 64 years; study 2: 131 patients, 76% male, age: 54.1
years) were included. Psychometric properties (study 2) were
conﬁrmed for the MacNew (3-factor-structure 67.4% explained
variance, cronbach’s alpha: 0.88–0.93) and acceptable for the
SF-36 (7-factorstructure, 73.7% explained variance, cronbach’s
alpha: 0.65–0.81). The outcome assessment (study 1) showed
that 74% of the patients report a substantial overall HRQL
improvement. The instructions of the touch-screen system were
considered clear (93%), time consumption was short (88%),
system was easy to use (84%) and the graphical interface was
intuitive (93%). Overall 86% of the patients rated the electronic
approach as positive or very positive. There were age differences
for the evaluation of the assessment. Patients 70 years and older
considered the mode of assessment as less clear, less intuitive and
not so easy to use (51%, 59%, 56%, all p < 0.01). CONCLU-
SION: The integration of PRO measures into clinical routine can
be implemented via touch-screen computers for the majority of
patients. For elderly patients different administration modes
should be considered.
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OBJECTIVES: Compare health outcomes and health resources
utilization in patients with hypertension attended in primary care
after 10 years of current clinical follow-up. METHODS: Cross-
sectional study. Setting: 9 urban health centres sampled in 1996
and 2006. Subjects: 1996: 1144 patients with hypertension;
2006: 1110 patients with hypertension. RESULTS: From 1996 to
2006, here are the RESULTS: sociodemographic variables:
622%/59.4% females, Age: 64.5 years (IC 95% 63.95–65.15);
64,6 years (CI 95% 63.78–65.45); Low cultural level 48%/
32.9%; Retired people 49%/41.3%; Housewives 28.8%/34%:
Living in couple 69.3%/76.1%. Health outcomes: Systolic Blood
Pressure Controlled (SBP < 140 mmHg) 40%/35.8% patients;
Dyastolic Blood Pressure Controlled (DBP < 90 mmHg).68.6%/
76.9% patients. SBP and DBP controlled 36%/32.1%
patients. Body Mass Index (BDI) 31.0 + 5.10 kg/m2/
31.13 kg/m2 IC95%[30.64–31.62]. Total Cholesterol
212.44 mg/dl IC95%[208.28–216.60] HDL- Cholesterol
53.35 mg/dl IC95%[51.52–55.18]. Calidad de vida: Nottingham
Health Proﬁle(0–100): 23.09 + 22.3 points/31.35 points
IC95%[27.8–34.34]. Health resources utilization: Clinical
appointments in one year: 4.5 + 3.6/13.12(IC95% 12,51–14,31).
Annual analysis: 61.8%/59.9%, Annual electrocardiogram
42.2%/30.2%, Annual Chest radiography 3%/4.1%. Annual
referrals: cardiologist: 5%/12.1%; ophthalmologist 20.0%/
12.8%; nephrologist 3%/2.9%; hospital emergencies 8.1%/
1.3%. CONCLUSION: Comparable samples. Unexpected
results in blood pressure control: better in dyastolic but worse in
systolic and global blood pressure. Persistent obesity. Quality of
life worsening. Disagreement between worse health outcomes
and larger health resources utilization.
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OBJECTIVES: To assess the attitudes and beliefs, of hypercho-
lesterolemic patients with high cardiovascular risk, about hyper-
cholesterolemia and its treatment in Spain. METHODS: An
observational, cross-sectional study was performed. Patients
with hypercholesterolemia, more than 18 years, treated with
statins for at least the last six months and with high cardiovas-
cular risk (CHD/CHD-equivalent, or having 2+ cardiovascular
risk factors, as deﬁned by NCEPIII) were recruited. Sociodemo-
graphic and clinical variables were collected, as well as data
regarding the attitudes and beliefs about hypercholesterolemia
and its treatment (through 7-items Likert scales and dichotomic
true/false variables). RESULTS: In total, 711 patients were
included, mean age 63 (SD 10) years, 65% males. Eighty-one
percent of patients were CHD/CHD equivalent. Ninety-one
percent of patients recognised that their health depends on their
own actions. They believe that their physician explains things
clearly to them (92%) and it is easy to follow their advice (91%).
However, patients declared they disagree to have been informed
about their cholesterol target level and the beneﬁts of reaching it
(17%), the risks of high cholesterol (12%), and the possible
adverse effects of lipid-lowering therapies (41%). Despite that,
75.5% of patients declared to take their medication daily and
87% agreed that myocardial infarction risk increases if they do
not take it, 49% believe nothing happens if they sporadically
forget taking a dose, being “just forgetting” the most frequently
reported reason for lack of compliance (34.2%). Although 96%
of patients agree that reducing cholesterol they reduce their car-
diovascular risk, 17% believe hypercholesterolemia is not a
disease since they feel good. CONCLUSION: Although patients
recognise the importance of hypercholesterolemia, the lack of
symptomatology reduces the perception of disease and increases
the lack of compliance due to forgetness. More information and
persuasion on the consequences of high cholesterol are needed to
make patients aware of the implied risk.
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OBJECTIVES: The objective of the study is to assess the effect of
each stage in the accepted translation methodology for PRO
measures (Wild et al. 2005): 2 forward translations and their
reconciliation, 2 back translations, back translation review,
developer review, harmonisation meeting, linguistic validation
interviews and 2 proof readings. METHODS: The questionnaire
chosen for this study was the Anti-Clot Treatment Scale (ACTS)
which had been translated into Canadian French, French and
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